Network Neurodegeneration in Alzheimer’s Disease via MRI Based Shape Diffeomorphometry and High-Field Atlasing

This paper examines MRI analysis of neurodegeneration in Alzheimer’s Disease (AD) in a network of structures within the medial temporal lobe using diffeomorphometry methods coupled with high-field atlasing in which the entorhinal cortex is partitioned into eight subareas. The morphometry markers for three groups of subjects (controls, preclinical AD, and symptomatic AD) are indexed to template coordinates measured with respect to these eight subareas. The location and timing of changes are examined within the subareas as it pertains to the classic Braak and Braak staging by comparing the three groups. We demonstrate that the earliest preclinical changes in the population occur in the lateral most sulcal extent in the entorhinal cortex (alluded to as transentorhinal cortex by Braak and Braak), and then proceeds medially which is consistent with the Braak and Braak staging. We use high-field 11T atlasing to demonstrate that the network changes are occurring at the junctures of the substructures in this medial temporal lobe network. Temporal progression of the disease through the network is also examined via changepoint analysis, demonstrating earliest changes in entorhinal cortex. The differential expression of rate of atrophy with progression signaling the changepoint time across the network is demonstrated to be signaling in the intermediate caudal subarea of the entorhinal cortex, which has been noted to be proximal to the hippocampus. This coupled to the findings of the nearby basolateral involvement in amygdala demonstrates the selectivity of neurodegeneration in early AD.

[1]  J G Csernansky,et al.  Labeled cortical mantle distance maps of the cingulate quantify differences between dementia of the Alzheimer type and healthy aging , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[2]  J. Kordower The prion hypothesis of Parkinson's disease: This hot topic just got hotter , 2014, Movement disorders : official journal of the Movement Disorder Society.

[3]  C. Duyckaerts,et al.  The extent of neurofibrillary pathology in perforant pathway neurons is the key determinant of dementia in the very old , 2000, Acta Neuropathologica.

[4]  J. Maunsell,et al.  Two‐dimensional maps of the cerebral cortex , 1980, The Journal of comparative neurology.

[5]  Michael I. Miller,et al.  Multi-structure network shape analysis via normal surface momentum maps , 2008, NeuroImage.

[6]  K. Kosaka,et al.  Neuropathological study of the amygdala in presenile Alzheimer's disease , 1990, Journal of the Neurological Sciences.

[7]  K. Tamura,et al.  Metabolic engineering of plant alkaloid biosynthesis. Proc Natl Acad Sci U S A , 2001 .

[8]  D. Cleveland,et al.  The Seeds of Neurodegeneration: Prion-like Spreading in ALS , 2011, Cell.

[9]  Michael I. Miller,et al.  Dynamic programming generation of boundaries of local coordinatized submanifolds in the neocortex: application to the planum temporale , 2003, NeuroImage.

[10]  Michael I. Miller,et al.  Diffeomorphic metric surface mapping in subregion of the superior temporal gyrus , 2007, NeuroImage.

[11]  Jane S. Paulsen,et al.  Regionally selective atrophy of subcortical structures in prodromal HD as revealed by statistical shape analysis , 2012, Human brain mapping.

[12]  C. Jack,et al.  Quantitative magnetic resonance techniques as surrogate markers of Alzheimer’s disease , 2004, NeuroRX.

[13]  Bradley T. Hyman,et al.  Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease , 1992, Neurology.

[14]  J. Morris,et al.  Tangles and plaques in nondemented aging and “preclinical” Alzheimer's disease , 1999, Annals of neurology.

[15]  L. Younes Shapes and Diffeomorphisms , 2010 .

[16]  Menno P. Witter,et al.  A pathophysiological framework of hippocampal dysfunction in ageing and disease , 2011, Nature Reviews Neuroscience.

[17]  M. Albert,et al.  Cognitive changes preceding clinical symptom onset of mild cognitive impairment and relationship to ApoE genotype. , 2014, Current Alzheimer research.

[18]  Stephen W. Scheff,et al.  Volumetric atrophy of the amygdala in Alzheimer's disease , 1991, Neurology.

[19]  Jun Ma,et al.  A Bayesian Generative Model for Surface Template Estimation , 2010, Int. J. Biomed. Imaging.

[20]  M. Mega,et al.  The Neuropsychiatric Inventory , 1994, Neurology.

[21]  C. P. Hughes,et al.  A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.

[22]  Jane S. Paulsen,et al.  Huntington disease: natural history, biomarkers and prospects for therapeutics , 2014, Nature Reviews Neurology.

[23]  Michael I. Miller,et al.  Bayesian Construction of Geometrically Based Cortical Thickness Metrics , 2000, NeuroImage.

[24]  T. Kemper,et al.  Amygdaloid changes in aging and dementia. , 1980, Archives of neurology.

[25]  L. Younes,et al.  Shape abnormalities of subcortical and ventricular structures in mild cognitive impairment and Alzheimer's disease: Detecting, quantifying, and predicting , 2014, Human brain mapping.

[26]  L. Hazrati,et al.  The prion hypothesis in Parkinson's disease: Braak to the future , 2013, Acta neuropathologica communications.

[27]  J. Morris The Clinical Dementia Rating (CDR) , 1993, Neurology.

[28]  David S. Lee,et al.  The diffeomorphometry of temporal lobe structures in preclinical Alzheimer's disease , 2013, NeuroImage: Clinical.

[29]  Thomas E. Nichols,et al.  Controlling the familywise error rate in functional neuroimaging: a comparative review , 2003, Statistical methods in medical research.

[30]  P. Yushkevich,et al.  Automated volumetry and regional thickness analysis of hippocampal subfields and medial temporal cortical structures in mild cognitive impairment , 2015, Human brain mapping.

[31]  Ronald Killiany,et al.  Structural Magnetic Resonance Imaging in Established and Prodromal Alzheimer Disease: A Review , 2003, Alzheimer disease and associated disorders.

[32]  V. Leirer,et al.  Development and validation of a geriatric depression screening scale: a preliminary report. , 1982, Journal of psychiatric research.

[33]  Teng Jiang,et al.  Prion-like Mechanisms in Alzheimer's Disease. , 2014, Current Alzheimer research.

[34]  L. Younes,et al.  Inferring changepoint times of medial temporal lobe morphometric change in preclinical Alzheimer's disease , 2014, NeuroImage: Clinical.

[35]  J. Morris,et al.  Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease , 1996, The Journal of Neuroscience.

[36]  D. Sparks,et al.  Amygdala cell loss and atrophy in Alzheimer's disease , 1992, Annals of neurology.

[37]  Ronald Melki,et al.  Prion-like transmission of protein aggregates in neurodegenerative diseases , 2010, Nature Reviews Molecular Cell Biology.

[38]  L. Younes,et al.  Diffeomorphometry and geodesic positioning systems for human anatomy. , 2014, Technology.

[39]  Michael I. Miller,et al.  Amygdalar atrophy in symptomatic Alzheimer's disease based on diffeomorphometry: the BIOCARD cohort , 2015, Neurobiology of Aging.

[40]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[41]  G. V. Van Hoesen,et al.  The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. , 1991, Cerebral cortex.

[42]  Mert R. Sabuncu,et al.  Statistical analysis of longitudinal neuroimage data with Linear Mixed Effects models , 2013, NeuroImage.

[43]  Michael I. Miller,et al.  Pattern Theory: From Representation to Inference , 2007 .

[44]  Denise C. Park,et al.  Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging and the Alzheimer's Association workgroup , 2011 .

[45]  Lei Wang,et al.  Distinct abnormalities of the primate prefrontal cortex caused by ionizing radiation in early or midgestation , 2013, The Journal of comparative neurology.

[46]  Denise C. Park,et al.  Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[47]  R. Saunders,et al.  The entorhinal cortex: an examination of cyto- and myeloarchitectonic organization in humans. , 1997, Cerebral cortex.